Epigral543332Specialty chemicals
Epigral management discussed FY27 margin guidance and inventory/debtor day improvements, with stock recovering from day's lows
By ScoutQuest · · 1 min read
- Expected EBITDA margin
- 20 to 25 percent
- Cost pass-through lag
- 3 months
- Specialty revenue share expected
- 70 percent
- Domestic business share
- 95 percent
- Debtor days
- 50 days
Heard on business television between 12:48:24 - 12:51:24 IST.
- Management guided 20-25% EBITDA margins to continue based on volume growth.
- Said high fixed stock and energy costs due to oil price increase create a 3-month lag before passing costs to B2B customers.
- Noted 70% of portfolio expected from specialty products, with 95% business domestic, making demand resilient to global headwinds and logistics issues.
- Debtor days improved to 50 from 64 days; inventory kept lower than usual (60-65 days normal) due to logistics delays.
- Stock recovered from being down 4.5% to down about 3% intraday on this commentary.
Watch at source
behind live
- 1Open on YouTube
- 2Drag the seek bar left
- 3Watch this moment
Also from Epigral
Epigral schedules one-on-one video-conference meeting with Kotak Mahindra Asset Management (Singapore) on 19 Nov 2026
17 Nov 2026
Epigral schedules one-on-one video conference with Kitara Capital on 20 November 2026
17 Nov 2026
Q2 FY27 call: revenue INR752 crores, PAT INR64 crores; CPVC and Epichlorohydrin plants near commissioning
7 Nov 2026
Source: Live TV News Channel · 3 Nov 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.